| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | 12,180.80▼ | 12,191.60▼ |
| MA10 | N/A | N/A | N/A | 12,171.80▲ | 12,298.20▼ |
| MA20 | N/A | N/A | N/A | 12,140.60▲ | 11,779.20▲ |
| MA50 | N/A | N/A | N/A | 12,270.12▼ | 10,994.66▲ |
| MA100 | N/A | N/A | N/A | 11,655.08▲ | 11,018.32▲ |
| MA200 | N/A | N/A | N/A | 11,005.52▲ | 9,877.94▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | 4.125▲ | -15.378▼ |
| RSI | N/A | N/A | N/A | 49.667▼ | 60.296▲ |
| STOCH | N/A | N/A | N/A | 64.849 | 49.228 |
| WILL %R | N/A | N/A | N/A | -23.445▲ | -30.824 |
| CCI | N/A | N/A | N/A | 72.744 | -74.201 |
|
Friday, July 26, 2024 03:11 AM
An advisory panel of the US Food and Drug Administration has questioned the design of a trial for AstraZeneca’s (LSE: AZN) Imfinzi (durvalumab), while confirming that it met the primary efficacy goal.
|
|
Friday, July 26, 2024 12:04 AM
The United Kingdom's stock market has recently experienced declines, influenced by disappointing trade data from China and its broader economic challenges. Amidst these market conditions, identifying ...
|
|
Thursday, July 25, 2024 01:02 PM
Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio), known for its strategic investments in the global health care sector, recently disclosed its N-PORT filing for the second quarter of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/07/24 | 12,116.00 | 12,332.00 | 12,114.00 | 12,180.00 | 1,450,635 |
| 25/07/24 | 12,300.00 | 12,376.00 | 11,540.00 | 12,060.00 | 1,784,165 |
| 24/07/24 | 12,196.00 | 12,242.00 | 12,034.0105 | 12,214.00 | 835,976 |
| 23/07/24 | 12,178.00 | 12,370.00 | 12,150.00 | 12,190.00 | 1,211,459 |
| 22/07/24 | 12,234.00 | 12,356.00 | 12,194.00 | 12,260.00 | 1,636,835 |
| 19/07/24 | 12,080.00 | 12,190.00 | 12,024.00 | 12,106.00 | 957,828 |
| 17/07/24 | 12,100.00 | 12,252.00 | 11,924.00 | 12,244.00 | 1,105,504 |
| 16/07/24 | 12,020.00 | 12,100.00 | 11,990.00 | 12,100.00 | 836,031 |
| 15/07/24 | 12,208.00 | 12,272.00 | 12,090.00 | 12,104.00 | 648,711 |
| 12/07/24 | 12,154.00 | 12,304.00 | 12,154.00 | 12,260.00 | 1,010,814 |
|
|
||||
|
|
||||
|
|